Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger

Stock Information for Lifecore Biomedical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lifecore Biomedical Inc.

Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches "Team Speedy" to Let the Public Follow Its Longest-Lived Mouse
Are MGLD, NRIM, PULM Obtaining Fair Deals for their Shareholders?
ACT NOW: The M&A Class Action Firm Is Investigating the Merger--LXP, LXFR, NRIM, and PULM
Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria
Halper Sadeh LLC is Investigating Whether SLP, HUN, OLN, PULM are Obtaining Fair Deals for their Shareholders
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--PULM, SLP, OLN, and HUN
Pulmatrix Announces First Quarter 2026 Financial Results
Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.